WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



Pages:   || 2 |

«Project Leader Kelly A. Shipkowski, Ph.D. NIEHS/DNTP/Toxicology Branch Nomination Background and Rationale Thallium, Tl, is a heavy metal that is ...»

-- [ Page 1 ] --

NTP Research Concept: Thallium Compounds

Project Leader

Kelly A. Shipkowski, Ph.D.

NIEHS/DNTP/Toxicology Branch

Nomination Background and Rationale

Thallium, Tl, is a heavy metal that is soft, malleable, and insoluble in water in its metallic

state. Thallium salts exist in a monovalent (+1) or trivalent (+3) state. Thallium and

thallium salts are currently used in the semiconductor and electronic industries, as

additives in fireworks, and in the manufacturing of imitation gems, optic lenses, thermometers, and machinery parts operating at sub-zero temperatures. Thallium and thallium salts were nominated by the U.S. Environmental Protection Agency’s Office of Land and Emergency Management (EPA’s OLEM) for subchronic toxicity studies to generate data to establish an oral reference dose (RfD) for protecting human health.

The EPA Integrated Risk Information System (IRIS) Toxicological Review of Thallium and Compounds (2009) evaluated the literature available for metallic thallium and eight

thallium compounds:

Thallium Compound Chemical Molecular Solubility in Water (Formula) CASRN Formula Weight (g/L) Metallic thallium (Tl) 7440-28-0 Tl 204.38 Insoluble Thallium (I) acetate 563-68-8 TlC2H3O2 263.43 Soluble Thallium (I) carbonate 6533-73-9 Tl2CO3 468.78 40.3 (15.5°C) Thallium (I) chloride 7791-12-0 TlCl 239.84 Very soluble (20°C) Thallium (I) nitrate 10102-45-1 TlNO3 266.39 95.5 (20°C) Thallium (I) oxide 1314-12-1 Tl2O 424.77 Decomposes to TlOH Thallium (III) oxide 1314-32-5 Tl2O3 456.76 Insoluble Thallium (I) selenite 12039-52-0 Tl2SeO3 535.72 No data Thallium (I) sulfate 7446-18-6 Tl2SO4 504.82 48.7 (20°C) There is potential for widespread human exposure to thallium due to its presence as a contaminant in drinking water in the vicinity of hazardous waste and industrial sites, via inhalation from fireworks emissions, and from instances of accidental or deliberate poisoning. Thallium has the potential to induce a broad spectrum of adverse health effects in humans, including alopecia, neurological, cardiovascular, reproductive, and developmental toxicity, and mortality at high doses. Case studies of human exposure indicate that thallium salts may be neurotoxicants, and results from animal studies suggest that thallium salts may induce reproductive and developmental effects including decreased sperm motility and count, low birth weight, and alterations in bone development. There are no available human or animal data on the potential carcinogenic activity of thallium compounds following oral exposure.

Thallium does not have a known biological function in humans, but it has been established that Tl+ can replace K+ in vital biological pathways. Tl+ is similar to K+ in ionic radius and electric charge and Tl+ has a ten-fold higher affinity for Na+/K+ ATPase than K+. The putative mechanism of thallium toxicity is thought to involve inhibition of the Na+/K+ ATPase pump and depolarization of membranes.

Human Exposure Human exposure to thallium and thallium salts can occur from anthropogenic and naturally occurring sources. The EPA Toxics Release Inventory (TRI) estimated that approximately 1.67 million pounds of thallium and thallium compounds were released from industrial sources in 2014. Thallium also occurs naturally in the Earth’s crust at an abundance of 0.7 – 1.0 parts per million (ppm), and soil thallium concentrations naturally range from 0.1 – 1.0 ppm.

A major concern for human exposure to thallium and thallium salts is through drinking water contamination following the release of thallium into the environment. Thallium is released into the atmosphere from a variety of industrial sources, including coal-fired power plants, mining operations, metal smelters, and cement plants. Limited data are available for thallium concentrations in ambient air, though the U.S. EPA (1988) estimated thallium concentrations near a coal-fired power plant to be approximately

0.08 parts per billion (ppb).

The EPA’s Maximum Contaminant Level (MCL) for drinking water and Human Health Water Quality Criteria (HHWQC) for thallium are currently set at 2.0 and 0.24 ppb, respectively. In California, the MCL and Public Health Goal (PHG) for thallium in drinking water are currently set at 2.0 and 0.1 ppb, respectively. All of these levels were derived based on a 90-day subchronic toxicity study performed by Midwest Research Institute (MRIGlobal, Kansas City, MO) for the EPA. In this study, male and female Sprague-Dawley rats were exposed to Tl2SO4 via oral gavage and the incidences of alopecia were considered as the critical endpoint.

Information from the Environmental Working Group’s (EWG’s) 2009 National Drinking Water Database showed that thallium had been detected in treated tap water in 34 states since 2004, exposing an estimated 8 million people. Of those reported instances, 31 were above EPA’s HHWQC (0.24 ppb) and California’s PHG (0.1 ppb), and 15 were above EPA’s and California’s MCL (2.0 ppb). The highest level of thallium reported was

3.15 ppb.

Thallium has been measured in the urine of the U.S. population as part of the National Health and Nutrition Examination Survey (NHANES). A slight decreasing trend was evident from 1999-2010, and, for the 2009-2010 reporting cycle, the geometric mean and 95th percentile concentrations for all participants were 0.144 μg/g creatinine and





0.410 μg/g creatinine, respectively. The urinary concentrations for ages 6-11 were slightly higher than those of the group as a whole.

Draft: NTP Board of Scientific Counselors Meeting – June 15-16, 2016 2 Knowledge Gaps The EPA IRIS assessment (2009) concluded that there was a lack of adequate data to derive an RfD or reference concentration (RfC) for human health following thallium exposure. In general, there are relatively few toxicity studies and those that are available are of poor quality, however specific knowledge gaps noted in the IRIS assessment included neurotoxicity, developmental and reproductive toxicity, genotoxicity, and carcinogenicity. The database limitations as well as the low confidence in the available studies hinder informed decisions on dose selection and route of exposure. A 90-day subchronic study of Tl2SO4 in rats (MRI, 1988) is considered to be the most informative study on toxicity following oral thallium exposure, and has been utilized by the EPA and OEHHA to derive drinking water guidelines for thallium contamination. However, the 2009 IRIS assessment indicated low confidence in the reported data and conclusions from the subchronic study. Limitations noted included dose selection was likely too low and that there were inconsistencies with the interpretation and reporting of data regarding instances of alopecia.

Dose selection for the subchronic study was deemed inappropriate for evaluation of alopecia, a trademark sign of thallium exposure and the most sensitive endpoint of toxicity in the study. A 14-day range-finding study (MRI, 1986) performed prior to the 90day study indicated hair follicle alterations alongside minimal decreases in body weight gain at a dose of 2.5 mg/kg/day Tl2SO4, however a dose of 0.25 mg/kg/day Tl2SO4, tenfold lower, was utilized as the high dose in the subchronic study. In addition, alopecia was the only reported treatment-related finding, however further review of the results indicated that there were difficulties distinguishing between normal hair cycling, selfbarbering, and incidences of alopecia.

Proposed Approach The goal of this research program is to evaluate the potential for water-soluble thallium salts to induce neurological, reproductive, and developmental toxicity following subchronic exposure in rodents. A systematic approach will be taken to select an appropriate and representative test compound, as there is low confidence in the thallium toxicity data currently in the literature. Numerous thallium salts are utilized in industrial applications and there is little information on the specific toxicity and/or use of individual compounds. Likewise, little information is available on the speciation of thallium in the environment, making compound selection based on occurrence and potential for human exposure difficult.

Thallium salts are found in two different oxidation states: a stable, water-soluble +1 state and a less stable, oxidizing +3 state. Due to the stability and water solubility of the +1 state, we propose utilizing a +1 thallium salt for evaluating subchronic toxicity following oral exposure. There is little basis to indicate that different +1 thallium salts will exert different toxicities in vivo. While human exposure to +3 thallium salts is also relevant, the potential instability of +3 thallium salts due to their oxidizing properties may not be ideal for oral exposure studies.

Draft: NTP Board of Scientific Counselors Meeting – June 15-16, 2016 3 Human exposure to thallium can occur through multiple routes including oral (drinking water, dietary), inhalation, and dermal. After considering the possible routes of exposure it was determined that oral exposure, either through drinking water or gavage, is the most relevant route of exposure for this program due to concerns regarding exposure through contaminated drinking water. Inhalation exposure is also relevant, as thallium is released from industrial and fireworks emissions, but is less of a concern. Due to their previous use as depilatory agents, thallium compounds are believed to be absorbed by the skin, but dermal exposure is not considered to be a major route of exposure for these compounds currently. While oral exposure will be the focus, steps may also be taken to extrapolate from oral exposure to other routes.

While the literature on thallium and thallium salts is limited, the majority of the available information is related to Tl2SO4, which is highly water-soluble, similar to other available thallium compounds. Tl2SO4 was previously used as a pesticide, but was banned in the U.S. in 1972 due to high, non-selective toxicity. Specific information regarding the current use of Tl2SO4 is limited, but Tl2SO4 could be a contaminant of groundwater near coal-fired power plants due to the presence of sulfates in the water near these operations.

Specific Aims

1) Select a representative test compound and evaluate stability in drinking water formulations.

While some information is available in the literature regarding the use of Tl2SO4, we propose to investigate the chemistry of several +1 and +3 thallium salts to aid in compound selection for the toxicology studies proposed below. This investigation will evaluate the solubility, pH, and the stability and speciation of various +1 and +3 thallium salts in water. Evaluations will also include stability and speciation in artificial gastric and intestinal fluids to mimic in vivo conditions.

2) Evaluate the subchronic toxicity of a representative thallium salt in rodents via exposure in drinking water, with the inclusion of endpoints to assess neurotoxicity and reproductive toxicity. Additional exposures during gestation and lactation will be included to broadly assess developmental toxicity.

We propose selecting a representative thallium salt for subchronic toxicity studies based on bulk availability, physicochemical properties (i.e. water-solubility, pH), and information on both current and past human exposures. Case studies of human exposure indicate that thallium is a neurotoxicant, and therefore the potential for neurotoxicity will be assessed. Based on the available background literature, endpoints for reproductive toxicity will be assessed and perinatal exposures will be included to evaluate developmental toxicity. Internal exposure to thallium will be assessed by measuring plasma and/or selected tissue concentrations, and the need for additional ADME and toxicokinetic studies will be determined. As thallium is a soluble metal, further evaluations of chronic toxicity and carcinogenicity may be warranted. Based on Draft: NTP Board of Scientific Counselors Meeting – June 15-16, 2016 4 the results of the subchronic studies, discussions will be initiated with agency partners to receive feedback on the value of specific additional work.

3) Use in vitro approaches and lower animal models to assess the biological activity of thallium salts.

The primary mechanism of toxicity of thallium is thought to be inhibition of the Na+/K+ ATPase pump and depolarization of membranes. We propose utilizing in vitro models to: a) better assess this mechanism of toxicity, and b) reduce uncertainty as to whether there are any substantial differences in toxicity between thallium compounds of the same valence state. In vitro assays to evaluate cytotoxicity, genotoxicity, and other potential biological targets, such as neurotoxicity, will be considered. Zebrafish screening may also be utilized for evaluation of different biological targets including developmental toxicity.

Significance and Expected Outcome Human exposure to thallium compounds via contaminated drinking water, particularly from industrial sources such as coal-fired power plants, may represent a significant human health concern. The U.S. EPA OLEM identified subchronic toxicity studies of thallium as a key research need, as the existing data in the literature are inadequate for establishing a RfD for human health risks following oral exposure to thallium or thallium salts. The information provided by these studies will serve to reduce uncertainty, characterize dose response, and more fully characterize potential hazards of thallium compounds, which may ultimately impact federal and state drinking water regulations.

–  –  –

ATSDR (Agency for Toxic Substances and Disease Registry). (1992) Toxicological Profile for Thallium.

CalEPA (California Environmental Protection Agency). (1999) Public Health Goal for Thallium in Drinking Water.

CDC (Centers for Disease Control and Prevention). (2015) Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, February 2015.

EWG (Environmental Working Group). (2009) National Drinking Water Database, Chemical Contaminants: Thallium (Total).

IPCS (International Programme on Chemical Safety). (1996) Environmental Health Criteria No. 182: Thallium.

IPCS. (1990) Poisons Information Monograph 525: Thallium.

MRI (Midwest Research Institute). (1986) Toxicity of thallium (I) sulfate (CAS NO. 7446in Sprague-Dawley rats. Volume 1: Range-finding (14-day) study [final report].

Docket ID: EPA-HQ-ORD-2008-0057-0005.



Pages:   || 2 |


Similar works:

«November 2010 The Impact of the H1N1 Pandemic on Canadian Hospitals Introduction Pandemic planning is a critical function for any health system. These plans aim to limit serious illness and death from a pandemic; they also ensure that essential health services are maintained and disruption of other health services is minimized. Achieving the goals of a pandemic plan requires the coordination of many agencies and institutions, from public health to acute care hospitals, and requires the...»

«Agronomy Research 13(4), 1112–1119, 2015 Evaluation of size distribution of fat globules and fat and protein content in Estonian Goat milk V. Tatar*, H. Mootse, A. Sats, T. Mahla, T. Kaart and V. Poikalainen Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences, Kreutzwaldi 1, EE51014 Tartu, Estonia, * Correspondence: vilma.tatar@emu.ee Abstract. The objectives of this study were to investigate size distribution of fat globules, fat and protein content in...»

«European Medicines Agency Evaluation of Medicines for Human Use London, 18 December 2008 EMEA/CPMP/VEG/4717/2003Rev.1 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DOSSIER STRUCTURE AND CONTENT FOR PANDEMIC INFLUENZA VACCINE MARKETING AUTHORISATION APPLICATION (Revision) September 2007 DRAFT AGREED BY BWP May 2008 DRAFT AGREED BY VWP 30 May 2008 ADOPTION CHMP FOR RELEASE FOR CONSULTATION 30 September 2008 END OF CONSULTATION (DEADLINE FOR COMMENTS) November-December AGREED...»

«STANDARD TREATMENT GUIDELINES AND ESSENTIAL DRUGS LIST FOR THE MINISTRY OF HEALTH, TONGA2007. Standard Treatment Guidelines Tonga 2007 Standard Treatment Guidelines and Essential Drugs List: Ministry of Health. First Edition, 2007 Copyright © 2007, Ministry of Health, Tonga All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, scanned or transmitted in any form without the permission of the copyright owner. Ministry of Health PO Box 59 Nuku’alofa...»

«The Oak Ridge Institute for Science and Education (ORISE) is a U.S. Department of Energy (DOE) institute focusing on scientific initiatives to research health risks from occupational hazards, assess environmental cleanup, respond to radiation medical emergencies, support national security and emergency preparedness, and educate the next generation of scientists. This document was prepared for the Centers for Disease Control and Prevention (CDC) by ORISE through an interagency agreement with...»

«The Benefits of Medical Research and the Role of the NIH May 2000 Office of the Chairman, Connie Mack http://jec.senate.gov THE BENEFITS OF MEDICAL RESEARCH AND THE ROLE OF THE NIH May 17, 2000 THE BENEFITS OF MEDICAL RESEARCH AND THE ROLE OF THE NIH EXECUTIVE SUMMARY The NIH Leads the Battle Against Disease ! Leading the battle against disease. As the world’s leading medical research institution, the NIH funds more than 35,000 research grants each year to scientists across the country making...»

«CMS Referral for Own Motion Review by DAB/MAC Appellant at ALJ Level ALJ Appeal Number 1-791627923 Beneficiary (if not the Appellant) List attached ALJ Decision Date August 19, 2011 Health Insurance Claim Number (HICN)* Specific Item(s) OR Service(s) Ambulance Service and Ground Mileage Provider, Practitioner OR Supplier Part A Part B American Medical Response NW Basis for referral Pre-BIPA Any Case CMS as a Participant Decision not supported by Error of law material to the outcome of Decision...»

«Mind, Brain, Body, and Behavior Foundations of Neuroscience and Behavioral Research at the National Institutes of Health Ingrid G. Farreras EDITOR-IN-CHIEF Caroline Hannaway EDITOR Victoria A. Harden EDITOR Mind, Brain, Body, and Behavior Biomedical and Health Research Volume 62 Recently published in this series: Vol. 61. J.-F. Stoltz (Ed.), Mechanobiology: Cartilage and Chondrocyte Volume 3 Vol. 60. J.-M. Graf von der Schulenburg and M. Blanke (Eds.), Rationing of Medical Services in Europe:...»

«Filed electronically on 6/27/16 via http://www.regulations.gov June 27, 2016 Mr. Andy Slavitt, Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-5517-P Mail Stop C4-26-05 7500 Security Boulevard Baltimore, MD 21244-1850 Re: Medicare Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for PhysicianFocused Payment Models – CMS-5517-P...»

«Gary Reiter 1955Andy Kaplan Rob Malow 2003 1959-2006 1953-2013 (My) Turning Points in HIV Treatment Adherence Research David Bangsberg, MD, MPH Director Massachusetts General Hospital Center for Global Health Professor Harvard Medical School Professor Harvard School of Public Health Visiting Professor Mbarara University of Science and Technology My Turning Points • 1992 Missed the first ART adherence study for over 10 years • 1995 Back to basics • 1996 Hope and fear • 2000 95% or else...»

«WHO/CDS/CSR/GIP/2005.8 Responding to the avian influenza pandemic threat Recommended strategic actions Communicable Disease Surveillance and Response Global Influenza Programme WHO/CDS/CSR/GIP/2005.8 Responding to the avian influenza pandemic threat Recommended strategic actions Communicable Disease Surveillance and Response Global Influenza Programme © World Health Organization 2005 All rights reserved. The designations employed and the presentation of the material in this publication do not...»

«Cosmetics 2015, 2, 211-224; doi:10.3390/cosmetics2030211 OPEN ACCESS cosmetics ISSN 2079-9284 www.mdpi.com/journal/cosmetics Review Nanotechnology-Based Cosmetics for Hair Care Jamie Rosen 1, Angelo Landriscina 1 and Adam J. Friedman 2,3,* 1 Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10467, USA; E-Mails: jrosen12@gmail.com (J.R.); angelo.landriscina@med.einstein.yu.edu (A.L.) 2 Department of Physiology and Biophysics, Albert Einstein College...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.